PE-backed MTIP has acquired a majority stake in Verifarma, a leading Spanish provider of pharmaceutical regulatory compliance solutions. Founded in 2007, Verifarma supports over 2,000 companies across 26 countries, specializing in serialization, traceability, and meeting complex global requirements for drug manufacturers, wholesalers, and distributors. The investment underscores growing demand for robust compliance infrastructure as regulators worldwide tighten supply chain oversight. MTIP's majority investment provides Verifarma with significant capital to expand its technology platform and global reach, potentially strengthening its position against larger competitors.

This move highlights the strategic importance of compliance technology within the pharmaceutical sector, where regulatory adherence is critical to market access and operational stability.